Published online Aug 16, 2023. doi: 10.12998/wjcc.v11.i23.5573
Peer-review started: May 19, 2023
First decision: June 1, 2023
Revised: June 10, 2023
Accepted: July 21, 2023
Article in press: July 21, 2023
Published online: August 16, 2023
Processing time: 88 Days and 21.9 Hours
Recent reports have described cases of metachronous breast metastasis in patients with nasopharyngeal carcinoma. However, no similar cases of synchronous breast metastasis have been reported, and evidence that can be used to support the clinical diagnosis of stage IV nasopharyngeal carcinoma in patients with concu
We report the case of a 46-year-old woman who visited our hospital with a right breast mass as the first symptom. The first pathological biopsy report suggested triple-negative breast invasive carcinoma. Subsequent imaging revealed a nasopharyngeal mass. Further puncture biopsy of the nasopharyngeal mass, molecular pathological Epstein–Barr virus in situ hybridization, and immunohistochemistry confirmed the diagnosis of nasopharyngeal carcinoma with breast metastasis. The patient did not undergo a mastectomy and achieved complete remission after chemotherapy and radiotherapy. She continued to receive oral chemotherapy as maintenance therapy and experienced no recurrence or metastasis during the 6-month follow-up period.
This case report suggests that breast specialists should carefully rule out secondary breast cancers when diagnosing and treating breast masses. Furthermore, clinicians should aim to identify the pathological type of the tumor to obtain the most accurate diagnosis and prevent excessive diagnosis and treatment.
Core Tip: The most common sites of distant metastasis in patients with nasopharyngeal carcinoma (NPC) are the bones, lungs, liver, and distant lymph nodes; metastasis to the breast is rare. To date, only a few cases of NPC metastasis to the breast have been reported in the literature, and all occurred secondary to the diagnosis and treatment of NPC. Here, we present the clinical characteristics, treatment strategies, and follow-up information for a patient with newly diagnosed stage IV NPC who developed synchronous breast metastasis. Furthermore, we conducted a literature review to provide evidence for comprehensive management of this condition.